Results 1 to 10 of about 925,579 (306)

Challenges in observing transcription–translation for bottom-up synthetic biology

open access: goldQRB Discovery
Synthetic biology aims to create a viable synthetic cell. However, to achieve this goal, it is essential first to gain a profound understanding of the cellular systems used to build that cell, how to reconstitute those systems in the compartments, and ...
Vadim G. Bogatyr, Gijs J. L. Wuite
doaj   +2 more sources

Monoclonal antibodies for COVID-19 therapy and SARS-CoV-2 detection

open access: yesJournal of Biomedical Science, 2022
The coronavirus disease 2019 (COVID-19) pandemic is an exceptional public health crisis that demands the timely creation of new therapeutics and viral detection.
Yu-Chyi Hwang   +8 more
doaj   +1 more source

Monoclonal antibodies against S2 subunit of spike protein exhibit broad reactivity toward SARS-CoV-2 variants

open access: yesJournal of Biomedical Science, 2022
Background The variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) harbor diverse spike (S) protein sequences, which can greatly influence the efficacies of therapeutics.
Shih-Han Ko   +9 more
doaj   +1 more source

UPF1: From mRNA Surveillance to Protein Quality Control

open access: yesBiomedicines, 2021
Selective recognition and removal of faulty transcripts and misfolded polypeptides are crucial for cell viability. In eukaryotic cells, nonsense-mediated mRNA decay (NMD) constitutes an mRNA surveillance pathway for sensing and degrading aberrant ...
Hyun Jung Hwang   +2 more
doaj   +1 more source

LC3B is an RNA-binding protein to trigger rapid mRNA degradation during autophagy

open access: yesNature Communications, 2022
LC3/ATG8 plays an essential role in autophagy. Here the authors show that LC3B exhibits RNA-binding ability and induces rapid degradation of target mRNAs via autophagic activation, highlighting the interplay between autophagy and RNA biology.
Hyun Jung Hwang   +5 more
doaj   +1 more source

Translation inhibition by rocaglates activates a species-specific cell death program in the emerging fungal pathogen Candida auris [PDF]

open access: yes, 2020
Fungal infections are a major contributor to infectious disease-related deaths worldwide. Recently, global emergence of the fungal pathogen Candida auris has caused considerable concern because most C.
Brown, Lauren E.   +6 more
core   +1 more source

Antibody cocktail effective against variants of SARS-CoV-2

open access: yesJournal of Biomedical Science, 2021
Background Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), an RNA virus with a high mutation rate.
Kang-Hao Liang   +10 more
doaj   +1 more source

Broadly neutralizing antibodies against Omicron variants of SARS-CoV-2 derived from mRNA-lipid nanoparticle-immunized mice

open access: yesHeliyon, 2023
The COVID-19 pandemic continues to threaten human health worldwide as new variants of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerge. Currently, the predominant circulating strains around the world are Omicron variants, which can
Ruei-Min Lu   +11 more
doaj   +1 more source

Nonsense-mediated mRNA decay factor UPF1 promotes aggresome formation

open access: yesNature Communications, 2020
Nonsense-mediated mRNA decay (NMD) is a translation-coupled process that eliminates mRNAs containing premature translation-termination codons. Here the authors identify a role for the NMD factor UPF1 in protein quality control, whereby truncated ...
Yeonkyoung Park   +7 more
doaj   +1 more source

mRNA-based vaccines and therapeutics: an in-depth survey of current and upcoming clinical applications

open access: yesJournal of Biomedical Science, 2023
mRNA-based drugs have tremendous potential as clinical treatments, however, a major challenge in realizing this drug class will promise to develop methods for safely delivering the bioactive agents with high efficiency and without activating the immune ...
Yu-Shiuan Wang   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy